Hot topics close

Outlook Therapeutics shares surge on late-stage wet AMD bevacizumab study results

Outlook Therapeutics (OTLK) announces that its ONS-5010 / LYTENAVA (bevacizumab) treatment met the main and secondary goals in a late-stage study of patients with neovascular...
News Archive
  • Shannen Doherty
    Shannen Doherty
    'Charmed' star Shannen Doherty says breast cancer has spread to ...
    8 Jun 2023
    13
  • Bearing
    Bearing
    Automotive Turbocharger Bearings Market Biggest Innovation with Top Key Players -NSK, SKF, JTEKT, NTN Bearing ...
    19 Aug 2023
    3
  • Dana White
    Dana White
    Dana White threatened to resign from UFC in defense of Joe Rogan amid 2022 controversies
    28 Mar 2024
    10
  • Volvo P1800
    Volvo P1800
    Cyan Racing P1800 gets stunning new GT variant
    15 Feb 2024
    4
  • Jake Angeli
    Jake Angeli
    Capitol riots: Who broke into the building?
    7 Jan 2021
    1
This week's most popular news